COMBINATION THERAPY OF AN ANTI CD20 ANTIBODY WITH A BTK INHIBITOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150125446A1
SERIAL NO

14532247

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to the combination therapy of an anti-CD20 antibody with a BTK inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with a type I anti-CD20 antibody or an afucosylated humanized B-Ly1 antibody and a BTK inhibitor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HOFFMANN-LA ROCHE INC150 CLOVE ROAD OVERLOOK AT GREAT NOTCH 8TH FLOOR LITTLE FALLS NJ 07424

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Klein, Christian Bonstetten, CH 571 9941
Yasuhiro, Tomoko Osaka, JP 16 53
Yoshizawa, Toshio Osaka, JP 42 488

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation